BNP Paribas Financial Markets’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,322
| Closed | -$707 | – | 4700 |
|
|
2024
Q4 | $707 | Buy |
+1,322
| New | +$707 | ﹤0.01% | 4275 |
|
|
2022
Q4 | – | Sell |
-129
| Closed | -$858 | – | 4027 |
|
|
2022
Q3 | $858 | Buy |
+129
| New | +$858 | ﹤0.01% | 3734 |
|
|
2020
Q3 | – | Sell |
-1,546
| Closed | -$15.7K | – | 3626 |
|
|
2020
Q2 | $15.7K | Sell |
1,546
-4,571
| -75% | -$46.4K | ﹤0.01% | 2874 |
|
|
2020
Q1 | $49.7K | Buy |
6,117
+4,373
| +251% | +$35.5K | ﹤0.01% | 2933 |
|
|
2019
Q4 | $15.1K | Sell |
1,744
-186
| -10% | -$1.61K | ﹤0.01% | 3395 |
|
|
2019
Q3 | $11.9K | Buy |
1,930
+611
| +46% | +$3.76K | ﹤0.01% | 3472 |
|
|
2019
Q2 | $21.9K | Sell |
1,319
-1,193
| -47% | -$19.8K | ﹤0.01% | 3240 |
|
|
2019
Q1 | $42K | Buy |
2,512
+2,351
| +1,460% | +$39.3K | ﹤0.01% | 3014 |
|
|
2018
Q4 | $1.84K | Sell |
161
-137
| -46% | -$1.57K | ﹤0.01% | 3139 |
|
|
2018
Q3 | $11.9K | Hold |
298
| – | – | ﹤0.01% | 2985 |
|
|
2018
Q2 | $8.41K | Buy |
+298
| New | +$8.41K | ﹤0.01% | 3211 |
|